Renaissance Technologies
KNTE

Renaissance Technologies’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Renaissance Technologies’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-887,740
Closed -$2.36M – 4109
2024
Q1 		$2.36M Buy
887,740
+312,761
+54% +$774K ﹤0.01% 1925
2023
Q4 		$1.36M Buy
574,979
+69,023
+14% +$122K ﹤0.01% 2204
2023
Q3 		$708K Buy
505,956
+168,156
+50% +$404K ﹤0.01% 2534
2023
Q2 		$1.02M Buy
337,800
+227,300
+206% +$876K ﹤0.01% 2455
2023
Q1 		$691K Buy
110,500
+7,100
+7% +$43.3K ﹤0.01% 2699
2022
Q4 		$631K Buy
103,400
+2,900
+3% +$23.6K ﹤0.01% 2808
2022
Q3 		$1.2M Buy
100,500
+4,900
+5% +$64.1K ﹤0.01% 2384
2022
Q2 		$1.21M Buy
95,600
+71,700
+300% +$667K ﹤0.01% 2585
2022
Q1 		$269K Buy
+23,900
New +$263K ﹤0.01% 3519
2021
Q4 		– Sell
-23,358
Closed -$538K – 4310
2021
Q3 		$538K Sell
23,358
-12,542
-35% -$273K ﹤0.01% 2860
2021
Q2 		$836K Buy
+35,900
New +$913K ﹤0.01% 2760

Renaissance Technologies's KNTE Position: Q2 2024 in Review

Renaissance Technologies sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 887,740 shares — an estimated $2.36M sold.

Renaissance Technologies first reported a position in KNTE in Q2 2021 and held it in 11 quarters. The position peaked at $2.36M in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

  • Renaissance Technologies reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 887,740 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $2.36M.
  • Renaissance Technologies first reported a position in Kinnate Biopharma Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Renaissance Technologies's Kinnate Biopharma Inc. Common Stock position peaked at $2.36M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.